Incident Heart Failure in Chronic Inflammatory Diseases: Is it Time to Rethink Stage A Heart Failure?∗
Publication date: Available online 8 April 2020Source: JACC: Heart FailureAuthor(s): Douglas L. Mann
Publication date: Available online 5 June 2020Source: Heart &LungAuthor(s): Zyad T. Saleh, Terry A. Lennie, Muhammad Darawad, Hamza Alduraidi, Rami A. Elshatarat, Issa M. Almansour, Debra K. Moser
Condition: Acurate Heart Failure Intervention: Other: MEESSI score Sponsor: University Hospital, Strasbourg, France Not yet recruiting
[The Conversation Africa] The rising temperatures that come with climate change present a global health challenge. There is scientific evidence that air pollution and hot weather increase the risk of cardiovascular disease hospital admissions - and may even end in death. Heart attacks, heart failure and abnormal heart rhythms are all examples of cardiovascular diseases. Evidence of the interaction between temperature and air pollution - and the combined effects on people's health - is also growing.
Authors: Abdel-Moneim A, Gaber AM, Gouda S, Osama A, Othman SI, Allam G Abstract Heart disease remains the leading cause of death globally. Heart failure (HF) is a clinical syndrome that results from impairment of the ability of the ventricle to fill with or eject blood. Over the past two decades, accumulated evidence has revealed the contribution of thyroid hormones to cardiovascular (CV) events, exerting their action through genomic and non-genomic pathways within the cardiomyocytes. The pivotal role of thyroid hormones in maintaining cardiac homeostasis has been observed in previous investigations which suggest ...
Authors: Tsujinaga S, Iwano H, Oshino T, Kadosaka T, Mizuguchi Y, Motoi K, Chiba Y, Koya T, Temma T, Kamiya K, Fukushima A, Koizumi T, Sato T, Takenaka S, Tada A, Ishizaka S, Sarashina M, Omote K, Kamada R, Konishi T, Sato T, Nagai T, Yamashita H, Anzai T Abstract Epirubicin-based chemotherapy carries a risk of inducing heart failure, although the frequency is rare. Bevacizumab, an anti-vascular endothelial growth factor monoclonal antibody, has recently been widely used in patients with recurrent breast cancer as a first-line chemotherapeutic agent. Heart failure or arterial thromboembolism has been reported as a ...
Authors: Imamura T, Narang N Abstract Abnormal hemodynamics are associated with poor clinical outcomes in patients with heart failure. Given the invasiveness and unfeasibility of routine right heart catheterization, non-invasive methodologies to monitor hemodynamics are needed. The CardioMEMS™ device is a recently developed technology that enables remote monitoring of pulmonary artery pressures via an implanted sensor located in the distal left pulmonary artery. Along with the CardioMEMS™, a remote dielectric system might be another promising device that reports indirect intra-thoracic filling pressures...
A deep-learning algorithm refines cardiac CT results by automatically eliminating...Read more on AuntMinnie.comRelated Reading: CT CAC directs statin therapy in African Americans CT CAC predicts risk of death in smokers AI spots heart disease on CT lung screening exams CT CAC linked to cardiovascular mortality in young adults Elevated CT CAC scores linked to future heart failure
CONCLUSIONS: the prevalence of symptoms was high and changed throughout the hospitalization period. Patients with poorer functional capacity and poorer performance had greater symptom overload. PMID: 32490991 [PubMed - in process]
Conclusion: The findings of the present study will help to determine whether ANC is effective or not on PC in patients with CHF. Study registration number: INPLASY202040077.
In conclusion, all people are susceptible to COVID-19, and older males and those with comorbid conditions are more likely to become severe cases. Even though COVID-19 is highly contagious, control measures have proven to be very effective, particularly wearing masks, which could prevent most infections.